logo
logo
AI Products 

GAN Market is Estimated to Witness Moderate Growth Owing to Increasing Investments in R&D

avatar
Kajal Patil
GAN Market is Estimated to Witness Moderate Growth Owing to Increasing Investments in R&D

Giant Axonal Neuropathy (GAN) is a rare genetic disorder characterized by progressive degeneration of the axons and affecting the central and peripheral nervous systems. It is caused due to mutations in the GAN gene and manifests through symptoms such as muscle weakness, joint contractures, loss of sensation, and balance and coordination problems. At present, only palliative treatments that help manage symptoms are available for GAN. The surge in R&D activities focused on developing curative therapies such as gene therapy holds promising growth prospects for GAN market.

The Global Giant Axonal Neuropathy Market is estimated to be valued at US$ 119.6 Mn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024-2031.

 Key players operating in the GAN market are Applied Genetic Technologies Corporation (AGTC), Audentes Therapeutics (acquired by Astellas Pharma), Passage Bio, Voyager Therapeutics, and Neuron Biopharma. Key Takeaways Key players: Key players operating in the GAN market are AGTC, Audentes Therapeutics, Passage Bio, Voyager Therapeutics and Neuron Biopharma. AGTC and Passage Bio are involved in developing gene therapies for treating GAN. Key opportunities: Increasing research focus on gene therapy as a potential cure for GAN presents high growth opportunities. Government and private funding to drive clinical trials would boost market revenues. Global expansion: Gan market players are actively conducting clinical trials across regions to bring novel treatment options to global patients. Favorable regulatory environment and healthcare reforms encourage adoption and commercialization of innovative therapies. Market drivers: Growing R&D investments by biopharma firms into developing effective cures is a key growth driver. Successful approvals and commercial launches of gene therapies will fuel the market significantly. Conferences centered on raising GAN awareness drives screening and diagnosis rates.

PEST Analysis Political: Government policies related to rare diseases and orphan drugs in various regions could impact the market growth either positively or negatively. Economic: Changes in economic conditions of major markets can influence healthcare expenditure and investment in R&D for orphan indications like GAN. Social: Rise in awareness about rare diseases and government initiatives to support patients could boost the market. Technological: Advancements in gene and cell therapies for neurological disorders hold promise to provide curative treatments for GAN in future. Major Market Regions North America holds the largest share of the global GAN market, primarily driven by high healthcare expenditure, availability of advanced treatment options, and presence of major players in the region. Fastest Growing Region The Asia Pacific region is poised to grow at the fastest pace during the forecast period. Factors such as rising healthcare spending, increasing patient pool, and improving access to diagnosis and care are expected to support market growth in the region.

Author Bio:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

 

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)

 

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

collect
0
avatar
Kajal Patil
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more